XACT ACE Observational Registry
Launched by XACT ROBOTICS LTD. · Jun 25, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The XACT ACE Observational Registry is a clinical trial that aims to gather important information about the use of a special robotic system called the XACT ACE during procedures for treating tumors. This trial is currently looking for participants, specifically adults aged 18 and older who are scheduled to undergo minimally invasive procedures guided by CT scans in the interventional radiology department. If you choose to participate, you will need to provide your consent for your data to be collected and used for this study.
Participants in this trial can expect to have their experiences and outcomes recorded to help researchers understand how well the XACT ACE Robotic System works in real-world settings. There are not many restrictions on who can join, so if you’re an adult undergoing the specified procedures, you likely qualify. This study is an opportunity to contribute to the advancement of treatment options for tumors, potentially benefiting future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. ≥ 18 years of age
- • 2. Subjects undergoing CT-guided, minimally invasive percutaneous procedures in the interventional radiology suite
- • 3. Subject is willing to sign informed consent for the purposes of data collection
- Exclusion Criteria:
- • 1. No exclusion criteria other than listed in the product Instructions for Use (IFU)
About Xact Robotics Ltd.
Xact Robotics Ltd. is a pioneering medical technology company dedicated to advancing minimally invasive procedures through its innovative robotic platform. With a focus on enhancing precision and efficiency in diagnostic and therapeutic interventions, Xact Robotics leverages cutting-edge robotics and imaging technologies to improve patient outcomes. The company is committed to rigorous clinical research and development, ensuring that its solutions meet the highest standards of safety and efficacy. By collaborating with healthcare professionals and institutions, Xact Robotics aims to transform the landscape of interventional medicine and provide new possibilities for patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Burlington, Massachusetts, United States
Sarasota, Florida, United States
Patients applied
Trial Officials
Mark Macedo
Study Director
XACT Robotics
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials